Jubilant Cadista Pharmaceuticals, Inc. recalls Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each
Jubilant Cadista recalls hormone tablets that failed stability testing at 3 months. Consumers should check NDC 59746-763-43 and lot 183222 for affected products.
Lower-risk recall
Failed dissolution specifications : failed results at the 3-month stability time point.
Contact the company & request your remedy
What happened, in plain English
Jubilant Cadista is recalling hormone tablets that failed stability testing after 3 months. This means the tablets may not work as intended over time, but it does not pose an immediate safety risk. Read more at govinfonow.com/recall/38350-jubilant-cadista-recalls-hormone-tablets-due-to-stability-issues.
Source Summary by GovInfoNow · govinfonow.com/recall/38350-jubilant-cadista-recalls-hormone-tablets-due-to-stability-issues · Updated October 5, 2026 · FDA enforcement record: FDA #D-1837-2019
Cite this page
“Jubilant Cadista Recalls Hormone Tablets Due to Stability Issues.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38350-jubilant-cadista-recalls-hormone-tablets-due-to-stability-issues. Based on FDA recall #D-1837-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1837-2019%22&limit=1).
Why it’s dangerous
The tablets failed stability testing at the 3-month mark, meaning they may not maintain their intended effectiveness over time. This is a quality issue rather than a safety hazard.
Who’s affected
People who own the specific hormone tablets with NDC 59746-763-43 and lot number 183222 are affected. Those using these tablets for birth control are most at risk.
How to tell if you have this one
Check for the NDC code 59746-763-43 and lot number 183222 on the packaging. The product is a carton with 3 blister cards each containing 28 tablets.
- Brand
Jubilant Cadista- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 59746-763-43 and lot number 183222 on the packaging.
Questions people ask
Is this product dangerous?
No, this is a stability issue that affects effectiveness, not safety. The product does not pose an immediate risk.
How do I know if I have the recalled product?
Check for NDC 59746-763-43 and lot number 183222 on the packaging. The product is a carton with 3 blister cards each containing 28 tablets.
What should I do if I have the recalled product?
The recall does not include a specific remedy, so no action is needed beyond checking the product details.
Contact Jubilant Cadista
We’ve drafted a message you can send Jubilant Cadista to request your refund or repair — edit it as you like.
Subject: Recall D-1837-2019 — Jubilant Cadista Jubilant Cadista Hello, I own a Jubilant Cadista that is covered by recall D-1837-2019 from Jubilant Cadista. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1837-2019 (July 9, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1837-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.